nach oben

Reactions Weekly

Erschienen in:

01.07.2020 | Case report

Eptacog-α

Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective and observational study of 63 patients, who received eptacog-α between 1 September 2015 and 30 June 2017, 4 patients [ages and sexes not stated] were described, who developed deep-vein thrombosis (DVT), ischaemic stroke or transient ischaemic attack (TIA) during treatment with eptacog-α for the reversal of anticoagulation-associated bleeding or refractory bleeding in cardiac surgery [dosages and routes not stated; not all times to reactions onsets and outcomes stated]. …

Marsh K, et al. Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven) utilization at a large academic medical center. Therapeutic Advances in Cardiovascular Disease 14: 14 May 2020. Available from: URL: http://doi.org/10.1177/1753944720924255

Titel: Eptacog-α
Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports
Publikationsdatum: 01.07.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-80345-y

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Eptacog-α

Deep-vein thrombosis, ischaemic stroke and transient ischaemic attack: 4 case reports

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Antiretrovirals

Dexamethasone/methylprednisolone/prednisone

Rituximab

Ramipril

Antineoplastics/antithymocyte-globulin

Vincristine labelling changed to prevent fatal medication errors